
BioVie Investor Relations Material
Latest events

AGM 2025
BioVie
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BioVie Inc
Access all reports
BioVie Inc. is a clinical stage biopharmaceutical company based in the United States, focusing on the discovery, development, and commercialization of innovative drugs for the treatment of chronic debilitating conditions. The company's pipeline includes key drug candidates like BIV201 for the treatment of ascites due to chronic liver cirrhosis as well as NE3107, aimed at treating neurodegenerative disorders. NE3107 is in clinical trial for mild to moderate Alzheimer's disease and Parkinson's disease. It is headquartered in Carson City, Nevada, and its shares are listed on the Nasdaq.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
BIVI
Country
🇺🇸 United States